Josh
Analyst
H.C. Wainwright
Equibles does not estimate personal net worth.
About Josh
Josh is recorded as Analyst at H.C. Wainwright. Josh has spoken on 1 earnings call across 1 company, most recently for Travere Therapeutics, Inc. on August 4, 2026. The companies whose calls Josh spoke on are classified in the Healthcare sector.
Josh on recent calls
“So last quarter, you had mentioned that the without nephrotic syndrome language would be more of an education opportunity rather than being a barrier to adoption.”
Affiliation history
-
H.C. Wainwright
Analyst
Transcript header (unverified)
Current